Reuters: Health News: Merck KGaA brain tumor drug fails clinical trial

Merck KGaA brain tumor drug fails clinical trial

FRANKFURT (Reuters) - Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical tri...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/OS9bpMUyIxw/us-merck-phaseiii-idUSBRE91O0BS20130225